| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/17/2009 | EP2070927A1 Fused heterocyclic derivative |
| 06/17/2009 | EP2070924A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2069365A1 Novel 5,7-disubstituted [1, 3]thiazolo [4, 5d]pyrimidin-2 (3h)-amine derivatives and their use in therapy |
| 06/17/2009 | EP2069364A1 Novel 5, 7-disubstituted [1, 3]thiazolo [4, 5-d]pyrimidin-2 (3h)-one derivatives and their use in therapy |
| 06/17/2009 | EP2069355A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| 06/17/2009 | EP2069020A2 Benzo[d]isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
| 06/17/2009 | EP2068931A1 Treatment of fibrosis |
| 06/17/2009 | EP2068920A2 Ccr2 antagonists for treatment of fibrosis |
| 06/17/2009 | EP2068903A2 S-nitrosothiol compounds and related derivatives |
| 06/17/2009 | EP2068896A1 Ionic hypertonic solutions based on undiluted seawater, their use as pharmaceutical compositions or medication and for preparing medication intended for treating nasal congestion |
| 06/17/2009 | EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 06/17/2009 | EP2068889A1 Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
| 06/17/2009 | EP1740591B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 06/17/2009 | EP1565431B1 Cannabinoid receptor ligands |
| 06/17/2009 | EP1491204B1 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | EP1435957B1 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | EP1383736B1 Peptide deformylase inhibitors |
| 06/17/2009 | CN100500193C Extract from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/17/2009 | CN100500175C Pharmaceutical composition that contains eucalyptus and orange oil |
| 06/16/2009 | US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
| 06/16/2009 | US7547696 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 06/16/2009 | US7547512 Nucleotide sequences comprisied of spike and nucleocapsid coding sequence for use as amplification tool in detection of coronaviral infection |
| 06/16/2009 | CA2487365C Piperidine derivatives as potassium channel blockers |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/16/2009 | CA2304975C Stabilized preparations for use in metered dose inhalers |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/11/2009 | WO2009073757A1 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| 06/11/2009 | WO2009073683A2 Methods of treating copd |
| 06/11/2009 | WO2009073300A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/11/2009 | WO2009071988A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 06/11/2009 | WO2009071625A1 Mequitazine for treating or preventing pathologies involving histamine h4 receptors |
| 06/11/2009 | WO2009033818A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033787A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033786A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033759A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033740A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033722A3 Use of a octreotide as a therapeutic agent |
| 06/11/2009 | WO2009033719A3 Use of a deslorelin and mastoparan as a therapeutic agent |
| 06/11/2009 | WO2002003918A3 Treating neural conditions resulting from spinal cord contusions and other causes |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/11/2009 | US20090149513 Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy |
| 06/11/2009 | US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders |
| 06/11/2009 | US20090149496 Inhibitors of the task-1 and task-3 ion channel |
| 06/11/2009 | US20090149475 Thioxanthine Derivatives and Their Use as Inhibitors of MPO |
| 06/11/2009 | US20090149448 Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases |
| 06/11/2009 | US20090149447 Novel M3 Muscarinic Acetylcholine Receptor Antagonists |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149428 Methods for Assessing the Predisposition or Susceptibility to COPD |
| 06/11/2009 | US20090149410 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090149399 Heterocyclic kinase inhibitors |
| 06/11/2009 | US20090149382 Modulation of lipid rafts |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/11/2009 | US20090149376 Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction |
| 06/11/2009 | US20090148542 Composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 06/11/2009 | US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148403 Interleukin-9 Antagonist Muteins and Their Pharmacological Methods of Use |
| 06/11/2009 | CA2706920A1 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| 06/11/2009 | CA2706898A1 Mequitazine for treating or preventing pathologies involving histamine h4 receptors |
| 06/11/2009 | CA2706883A1 Methods of treating copd |
| 06/11/2009 | CA2704266A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP2067779A1 Tiotropium salts, method for their production and medicinal formulas containing them |
| 06/10/2009 | EP2067777A1 Oxepin derivative |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067487A2 Immunomodulatory formulations and methods for use thereof |
| 06/10/2009 | EP2066669A1 Adenosine derivatives as a2a receptor agonists |
| 06/10/2009 | EP2066655A2 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 06/10/2009 | EP2066639A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 06/10/2009 | EP2066628A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 06/10/2009 | EP2066321A2 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 06/10/2009 | EP1844001B1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 06/10/2009 | EP1802347B1 Anti-snoring composition |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497377C SARS coronavirus structure protein ORF3 and its use |
| 06/10/2009 | CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496530C Traditional Chinese medicinal composition for treating coronary heart disease and its preparation method |
| 06/10/2009 | CN100496298C Process for producing liquid formulation containing raw yeast and liquid formulation |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer |
| 06/09/2009 | CA2404225C Medicament container with same side airflow inlet and outlet and method of use |